Stocks to Watch: Bancroft Uranium Inc (OTC BB: BCFT), NewMarket Technology, Inc. (OTC BB:NMKT) , Genesis Technology Group, Inc. (OTC BB:GTEC), Oramed Pharmaceuticals Inc. (OTCBB: ORMP), LaPolla Industries, Inc. (OTC BB:LPAD)
Featured Stock: Bancroft Uranium Inc
(OTC BB: BCFT)
Current Price (0.81)
http://www.smallcapstockanalyst.com/
Bancroft Announces Further Drilling Results at Monmouth Uranium Project
Scottsdale AZ, June 4, 2008 ---- Bancroft Uranium Inc. (OTCBB: BCFT) (“Bancroft” or the “Company”) is pleased to announce further drilling results from the Spring 2008 surface drill program conducted at the Monmouth Uranium Project, near Bancroft Ontario. The Company today is releasing assay results from drill holes 08-16 through 08-28 as outlined below.
The 2008 Exploration Phase 1 drill program commenced on February 25th and was designed to focus on areas in and around the historical drill results from the 1969 program bringing it into modern N.I. Policy 43-101 compliance, a recognized world mining standard. The drilling is also designed to extend the known strike length of the skarn which hosts the uranium mineralization with the aim of expanding the current estimated 1,800,000 lbs U3O8 potential at Monmouth.
This second series of drilling assays and intervals are from holes drilled over an additional 200 feet of strike length exposure of the host rock skarn (altered limestone) as follow up to results released on May 29th from the initial 300 feet. In total, the combined results cover drilling conducted over 500 feet of strike on the deposit. The historical drilling in 1969 covered a zone approximately 1,500 feet in length.
Assays of 0.747lb/51.4’ and 1.134lb/23.9’ in holes 08-24 and 08-25 represent the best results from this series of holes. Significant results are as follows. Assays are noted as lb representing lbs/ton U3O8 over feet:
08-16 - 0.309 lb/ 29.6’ from 49.6 to 79.2 feet,
08-17- 0.337lb/10.9’ from 35.2 to 46.1 feet and 0.469lb/2.4’ from 92.1 to 94.5 feet
08-18- 0.316lb/5.2’ from 15.1 to 20.3 feet; 0.125lb/4.6’ from 37.1 to 41.7 feet and 0.467lb/8.0’ from 55.0 to 63.0 feet
08-19- 0.397lb/49.2’ from 5.2 to 54.4 feet including 0.365lb/9.0’ from 5.2 to 14.2 feet and 0.646lb/10.4’ from 18.9 to 29.3 feet and 0.565lb/14.5’ from 34.0 to 48.5 feet. Also 0.595lb/17.3’ from 71.0 to 88.3 feet
08-22 - 0.717lb/18.5’ from 73.0 to 91.5 feet
08-23 - 0.401lb/9.8’ from 39.4 to 49.2 feet; 0.374lb/7.7’ from 55.4 to 63.1 feet; 0.794lb/33.3’ from 81.6 to 114.9 feet and 0.486lb/3.9’ from 125.7 to 129.6 feet
08-24 - 0.495lb/19.8’ from 56.0 to 75.8 feet and 0.747lb/51.4’ from 104.9 to 156.3 feet
08-25 - 1.134lb/23.9’ from 103.7 to 127.6 feet
08-25A - 0.420lb/55.1’ from 69.0 to 124.1 feet including 0.363lb/26.7’ from 73.9 to 100.6 feet and 0.656lb/19.2’ from 104.9 to 124.1 feet
08-26 - 0.389lb/31.9’ from 46.8 to 78.7 feet; 0.526lb/5.0’ from 119.0 to 124.0 feet and 0.507lb/17.1’ from 143.4 to 160.5 feet and 0.369lb/21.1’ from 188.7 to 209.8 feet
08-26A - 0.633lb/36.7’ from 135.9 to 172.6 feet including 0.788lb/18.1’ from 135.9 to 154.0 feet and 0.683lb/13.0’ from 159.6 to 172.6 feet.
08-27 - 5.377lb/2.1’ from 38.2 to 40.3 feet and 0.611lb/10.2’ from 66.2 to 76.4 feet
08-28 - 0.643lb/5.1’ from 52.5 to 57.6 feet; 0.352lb/14.2’ from 124.0 to 138.2 feet including 0.304lb/5.0’ from 124.0 to 129.0 feet and 0.521lb/6.5’ from131.7 to 138.2 feet; 0.525lb/26.3’ from 168.0 to 194.3 feet including 1.618lb/3.3’ from 172.8 to 176.1 feet and 0.578lb/13.7’ from 180.6 to 194.3 feet.
To date, Company engineers have verified the location, thickness and flat lying geometry of the uranium bearing skarn system intersected in the historical drilling. U3O8 assays have been returned from both uraninite bearing bright orange-colored calcite alteration in the skarn and from several pegmatite bodies in and adjacent to the skarn package. Initial assay results from the skarn rocks appear to validate the historical data. The geological modeling of the deposit is now coming into focus with the alteration zone rock package dipping at a fairly consistent 25-30 degrees, amenable to a potential open pit scenario.
All of Bancroft Uranium’s exploration programs are designed and supervised by Qualified Persons (“QP”) under the N.I. Policy 43-101, who ensure that programs are carried out using current industry “Best Practices”. The spring 2008 drilling program was supervised by Murray McGill P.Geo (QP). The NQ size core was logged by Mr. McGill and split on-site. Half core samples were analyzed using standard Delayed Neutron Counting (DNC) methods by Activation Laboratories in Ancaster, Ontario. Activation Laboratories employs rigorous in-house QA/QC procedures in the DNC process.
Bancroft will release a third series of drill results shortly.
For inquiries from the public and media concerning the Monmouth Uranium Project please contact Greenspirit Strategies at 1-877-54 GREEN or 1-877-544-7336. For shareholder and investor information please contact investor relations at 1-866-860-2995
ABOUT BANCROFT URANIUM INC. (OTCBB: BCFT)
Bancroft Uranium Inc. is an exploration Company which intends to develop Uranium assets in North America. Bancroft’s initial asset, the Monmouth Uranium Project is envisioned to have the potential of a low cost, open pit uranium producer located close to infrastructure and end product buyers.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our uranium properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
Bancroft Uranium Inc.
- - - - - - - - - - - - - - - - - -
P. L. Hammond, C.A.
President and Chief Executive Officer
To find out more about Bancroft Uranium Inc. (OTCBB: BCFT), visit our website at http://www.bancrofturanium.com/.
Public and Media Information: 1-877-544-7336
Shareholder and Investor Information: 1-866-860-2995
Source: Bancroft Uranium Inc.
For an in-depth analyst report, please visit : http://www.smallcapstockanalyst.com/
NewMarket Technology, Inc.
(OTC BB:NMKT)
Current Price (0.13)
www.SmallCapStockAnalyst.com
DALLAS, TX----Jun 4, 2008 -- NewMarket Technology, Inc. (OTC BB:NMKT.OB - News) has scheduled a Webcast for Monday, June 9, 2008 at 9 am EDT to announce a corporate and management realignment to support an overall repositioning of the Company in the marketplace. NewMarket Technology was recently announced as the fastest-growing technology company in the Dallas-Fort Worth (DFW) area for the second year in a row on the Metroplex Technology Business Council's (MTBC) Tech Titan Fast 50, compiled by Deloitte. NewMarket is the only company to be ranked number one more than once on the Tech Titan Fast 50. This is the fourth year in a row the company has been named to the Tech Titan's list. The Tech Titan Fast 50 recognizes the 50 fastest-growing technology companies in the DFW area, based on percentage revenue growth over five years (2002 to 2006) as well as percentage revenue growth over one year (2005 to 2006). The Tech Titans Award Ceremony was held Saturday, September 29th. For more information on the Tech Titan awards, please visit http://www.metroplextbc.org/techtitans/index.html.
Genesis Technology Group, Inc.
(OTC BB:GTEC)
Current Price (0.22)
www.SmallCapStockAnalyst.com
LAIYANG, China, June 3 -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC - News; ''Genesis'' or the ''Company''), a leading pharmaceutical company in the People's Republic of China, today announced that on May 30, 2008, it successfully completed a private placement of an aggregate principal amount of $30,000,000 of its three year convertible notes (the ''Notes''). Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that earns, enhances and markets equity positions in small to mid-sized Chinese enterprises. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.genesis-china.net/.
Oramed Pharmaceuticals Inc.
(OTCBB: ORMP)
Current Price (0.76)
www.SmallCapStockAnalyst.com
JERUSALEM, June 4 -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB - News; http://www.oramed.com), a developer of oral delivery systems, announced today that it has been selected to display its abstract, entitled Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in Healthy Subjects, at the upcoming 68th Annual American Diabetes Association's Scientific Sessions Conference in San Francisco, highlighting the successful results from its oral insulin trials on healthy volunteers. Oramed Pharmaceuticals' is an Israeli based company focused on the development of oral delivery solutions based on proprietary technology. Diabetes is one of the most rapidly growing diseases in the world and is one that requires constant and often unpleasant monitoring and drug therapy regimen. Oramed is currently developing an orally soft gel insulin capsule for the treatment of diabetes. The Company is also pursuing the development of oral delivery solutions for other drugs and vaccines. For more information on Oramed Pharmaceuticals please visit our website: http://www.oramedpharma.com/
LaPolla Industries, Inc.
(OTC BB:LPAD)
Current Price (0.76)
www.SmallCapStockAnalyst.com
HOUSTON, TX----Jun 4, 2008 -- LaPolla Industries, Inc. (OTC BB:LPAD.OB - News), a leading national manufacturer and supplier of spray foam and coatings designed to reduce energy consumption in the commercial and residential markets, announced today that it has signed a definitive agreement to acquire the assets of AirTight Marketing & Distribution, Inc. ("AirTight"). LaPolla Industries, Inc. is a national manufacturer of foam and coating products targeting commercial, industrial and residential applications in the roofing and perimeter insulation construction industries. Additional information about LaPolla is available on the World Wide Web at www.lapollaindustries.com.
Smallcapstockanalyst.com is owned and operated by Iron Consulting LLC
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Smallcapstockanalyst.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive fifty thousand dollars from Equity Alliance Intl. for one months of internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
